0001746726-18-000003.txt : 20180802 0001746726-18-000003.hdr.sgml : 20180802 20180801173148 ACCESSION NUMBER: 0001746726-18-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180802 DATE AS OF CHANGE: 20180801 EFFECTIVENESS DATE: 20180802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virion Therapeutics, LLC CENTRAL INDEX KEY: 0001746726 IRS NUMBER: 274966374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-317356 FILM NUMBER: 18985901 BUSINESS ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 BUSINESS PHONE: 800-841-9303 MAIL ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 D/A 1 primary_doc.xml X0708 D/A LIVE 0001746726 Virion Therapeutics, LLC 7 CREEK BEND COURT NEWARK DE DELAWARE 19711 800-841-9303 DELAWARE None None Limited Liability Company true 2018 Bernard Rudnick 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Andrew Luber 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Biotechnology No Revenues 06b true 0001746726-18-000002 2018-06-28 false true false 25000 5500000 3736402 1763598 true 5 65 0 0 0 false Virion Therapeutics, LLC /s/ Bernard Rudnick Bernard Rudnick CEO 2018-08-01